A number of factors will drive this growth, including an increase in injury rates, an aging population and more technologically advanced implant options. Arthrex was the leading company in sports medicine implants market in 2011, with a 23 percent share worth over $200 million.
More Articles on Sports Medicine:
Drs. Paul Saenz, Don Roberts Named to Medical Staff for 2012 U.S. Olympic Team
Sports Medicine Experts Seek Better Guidelines for Athletes’ Conditioning
UPMC, NHL’s Pittsburgh Penguins Partner for Sports Performance Center
